- Home
- AIXI vs PULM Comparison
AIXI vs PULM Comparison
Compare AIXI & PULM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIXI
- PULM
- Stock Information
- Founded
- AIXI 2001
- PULM 2003
- Country
- AIXI China
- PULM United States
- Employees
- AIXI N/A
- PULM N/A
- Industry
- AIXI Computer Software: Prepackaged Software
- PULM Biotechnology: Pharmaceutical Preparations
- Sector
- AIXI Technology
- PULM Health Care
- Exchange
- AIXI Nasdaq
- PULM Nasdaq
- Market Cap
- AIXI 35.4M
- PULM 33.2M
- IPO Year
- AIXI 2023
- PULM N/A
- Fundamental
- Price
- AIXI $2.44
- PULM $7.43
- Analyst Decision
- AIXI
- PULM
- Analyst Count
- AIXI 0
- PULM 0
- Target Price
- AIXI N/A
- PULM N/A
- AVG Volume (30 Days)
- AIXI 138.4K
- PULM 34.2K
- Earning Date
- AIXI 05-15-2025
- PULM 08-12-2025
- Dividend Yield
- AIXI N/A
- PULM N/A
- EPS Growth
- AIXI N/A
- PULM N/A
- EPS
- AIXI N/A
- PULM N/A
- Revenue
- AIXI $70,314,315.00
- PULM $1,921,000.00
- Revenue This Year
- AIXI $26.84
- PULM N/A
- Revenue Next Year
- AIXI N/A
- PULM $134.88
- P/E Ratio
- AIXI N/A
- PULM N/A
- Revenue Growth
- AIXI 18.84
- PULM N/A
- 52 Week Low
- AIXI $2.06
- PULM $1.78
- 52 Week High
- AIXI $8.31
- PULM $10.40
- Technical
- Relative Strength Index (RSI)
- AIXI 33.73
- PULM 49.28
- Support Level
- AIXI $2.31
- PULM $8.49
- Resistance Level
- AIXI $3.10
- PULM $8.75
- Average True Range (ATR)
- AIXI 0.20
- PULM 0.42
- MACD
- AIXI -0.05
- PULM -0.14
- Stochastic Oscillator
- AIXI 4.60
- PULM 0.11
About AIXI XIAO-I Corporation
XIAO-I Corp is an AI industrialization company focusing on the AI Cognitive Intelligence platform. The platform combines six core technologies including Natural Language Processing, Speech Processing, Computer Vision, Machine Learning, Affective Computing, Data Intelligence, and Hyper- automation. Based on the platform, The company developed products and solutions in the fields of Al+ Contact Center, Al+ Finance, Al+ City Public Service, Al+ Architecture, Al+ Metaverse, Al+ Manufacturing, and Al+ Healthcare. It generates revenue from the sale of software products and services, M&S services, and the sale of cloud platform products.
About PULM Pulmatrix Inc.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).